A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer

por Alvarado, Michael D., Prasad, Che, Rothney, Megan, Cherbavaz, Diana B., Sing, Amy P., Baehner, Frederick L., Svedman, Christer, Markopoulos, Christos J.
Publicado 2015

Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effect

por Magi-Galluzzi, Cristina, Maddala, Tara, Falzarano, Sara Moscovita, Cherbavaz, Diana B., Zhang, Nan, Knezevic, Dejan, Febbo, Phillip G., Lee, Mark, Lawrence, Hugh Jeffrey, Klein, Eric A.
Publicado 2016

Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies

por Knezevic, Dejan, Goddard, Audrey D, Natraj, Nisha, Cherbavaz, Diana B, Clark-Langone, Kim M, Snable, Jay, Watson, Drew, Falzarano, Sara M, Magi-Galluzzi, Cristina, Klein, Eric A, Quale, Christopher
Publicado 2013

The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubici...

por Penault-Llorca, Frédérique, Filleron, Thomas, Asselain, Bernard, Baehner, Frederick L., Fumoleau, Pierre, Lacroix-Triki, Magali, Anderson, Joseph M., Yoshizawa, Carl, Cherbavaz, Diana B., Shak, Steven, Roca, Lise, Sagan, Christine, Lemonnier, Jérôme, Martin, Anne-Laure, Roché, Henri
Publicado 2018

The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant tra...

por Perez, Edith A., Baehner, Frederick L., Butler, Steven M., Thompson, E. Aubrey, Dueck, Amylou C., Jamshidian, Farid, Cherbavaz, Diana, Yoshizawa, Carl, Shak, Steven, Kaufman, Peter A., Davidson, Nancy E., Gralow, Julie, Asmann, Yan W., Ballman, Karla V.
Publicado 2015

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

por Solin, Lawrence J., Gray, Robert, Baehner, Frederick L., Butler, Steven M., Hughes, Lorie L., Yoshizawa, Carl, Cherbavaz, Diana B., Shak, Steven, Page, David L., Sledge, George W., Davidson, Nancy E., Ingle, James N., Perez, Edith A., Wood, William C., Sparano, Joseph A., Badve, Sunil
Publicado 2013

Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study

por Iwata, Hiroji, Masuda, Norikazu, Yamamoto, Yutaka, Fujisawa, Tomomi, Toyama, Tatsuya, Kashiwaba, Masahiro, Ohtani, Shoichiro, Taira, Naruto, Sakai, Takehiko, Hasegawa, Yoshie, Nakamura, Rikiya, Akabane, Hiromitsu, Shibahara, Yukiko, Sasano, Hironobu, Yamaguchi, Takuhiro, Sakamaki, Kentaro, Bailey, Helen, Cherbavaz, Diana B., Jakubowski, Debbie M., Sugiyama, Naoko, Chao, Calvin, Ohashi, Yasuo
Publicado 2018

A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone

por Rakovitch, Eileen, Nofech-Mozes, Sharon, Hanna, Wedad, Baehner, Frederick L., Saskin, Refik, Butler, Steven M., Tuck, Alan, Sengupta, Sandip, Elavathil, Leela, Jani, Prashant A., Bonin, Michel, Chang, Martin C., Robertson, Susan J., Slodkowska, Elzbieta, Fong, Cindy, Anderson, Joseph M., Jamshidian, Farid, Miller, Dave P., Cherbavaz, Diana B., Shak, Steven, Paszat, Lawrence
Publicado 2015